Abbott gains FDA nod for blood Dx; Some pacemaker plastics appear to degrade;

 @FierceMedDev: SurgiQuest pulled in $18.5M in new funding for an abdominal cavity surgical tool. Release | Follow @FierceMedDev

@MarkHFierce: Another day, another lawsuit against a faulty metal hip replacement--this time against Biomet. Story | Follow @MarkHFierce

 @DamianFierce: The Israeli medical device industry is on the up-and-up, and Medtronic is paying attention, an exec says. News | Follow @DamianFierce

> Abbott Laboratories ($ABT) got FDA approval for the Architect AFP assay, a blood diagnostic designed to aid in cancer management and detect openings of the brain or spinal cord. More

> Sorin Group ($SRN) notched its first North American implant of the Paradym implantable defibrillator. News

> Micro Machine, a device manufacturer that works with DePuy and Zimmer ($ZMH), is expanding its Warsaw, MI, plant and hiring 60 people. Article

> MichBio, a Michigan life sciences industry association, is joining the Medical Device Innovation Consortium, a public-private outfit uniting the FDA, devicemakers and trade groups. Release

> Contract manufacturer Laserage is expanding into the medical device world with its acquisition of a majority interest in Venta Medical, a California device CMO. Item

> The FDA is looking for industry nominees to join CDRH's Device Good Manufacturing Practice Advisory Committee as a non-voting member. Story

> Some silicone-urethane plastics used for devices such as pacemakers and defibrillators degrade in a previously unknown way. Story

Biotech News

 @FierceBiotech: In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Story | Follow @FierceBiotech

 @JohnCFierce: At the very least, Merck should redesign the patient selection process on MK-8931 and concentrate on mild/prodomal Alzheimer's cases only. | Follow @JohnCFierce

 @RyanMFierce: AstraZeneca has answered German price cuts to drugs with $AZN workforce cuts of 400-650 workers in the country. Release | Follow @RyanMFierce

> FDA blamed for stymying new antibiotics. Story

> Chelsea Therapeutics sinks on latest PhIII results of lead fainting med. News

> German biotech Wilex slashes staff after Phase III misfire. Report

Pharma News

@FiercePharma: Eli Lilly taps India's Strides Arcolab to make/distribute generic cancer drugs in emerging markets. More | Follow @FiercePharma

> Closely-watched Novartis patent case wraps in India. Story

> AZ blames German pricing for up to 625 job cuts. Article

Drug Delivery News

> Leukemia nanoparticles get drugs to the right spot. News

> Team shoos away superbugs with puffs of powder. Report

> Iluvien stumbles on rocky road to market in U.K. Article

> Dissolving fabric could stop pregnancy, HIV. Story

Biomarkers News

> Experts: Britain's NHS must build genetic testing infrastructure. News

> In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Article

> Supreme Court to tackle gene patent case. Item

> Gene analysis marks new targets against childhood cancer. Report

> Biotech grabs $2M to discover biomarkers for personalized autism treatment. News

> Biomarker spotted for colon cancer stem cells. Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.